Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Advances in methods for reducing mitochondrial DNA disease by replacing or manipulating the mitochondrial genome.

Rai PK, Craven L, Hoogewijs K, Russell OM, Lightowlers RN.

Essays Biochem. 2018 Jul 20;62(3):455-465. doi: 10.1042/EBC20170113. Print 2018 Jul 20. Review.

PMID:
29950320
2.

Scientific and Ethical Issues in Mitochondrial Donation.

Craven L, Murphy J, Turnbull DM, Taylor RW, Gorman GS, McFarland R.

New Bioeth. 2018 Apr;24(1):57-73. doi: 10.1080/20502877.2018.1440725.

3.
4.

Extended Screening Costs Associated With Selecting Donors for Fecal Microbiota Transplantation for Treatment of Metabolic Syndrome-Associated Diseases.

Craven LJ, Nair Parvathy S, Tat-Ko J, Burton JP, Silverman MS.

Open Forum Infect Dis. 2017 Nov 6;4(4):ofx243. doi: 10.1093/ofid/ofx243. eCollection 2017 Fall.

5.

Novel reproductive technologies to prevent mitochondrial disease.

Craven L, Tang MX, Gorman GS, De Sutter P, Heindryckx B.

Hum Reprod Update. 2017 Sep 1;23(5):501-519. doi: 10.1093/humupd/dmx018. Review.

PMID:
28651360
6.

Faecal microbiota transplantation: Where did it start? What have studies taught us? Where is it going?

Chanyi RM, Craven L, Harvey B, Reid G, Silverman MJ, Burton JP.

SAGE Open Med. 2017 May 11;5:2050312117708712. doi: 10.1177/2050312117708712. eCollection 2017. Review.

7.

Recent Advances in Mitochondrial Disease.

Craven L, Alston CL, Taylor RW, Turnbull DM.

Annu Rev Genomics Hum Genet. 2017 Aug 31;18:257-275. doi: 10.1146/annurev-genom-091416-035426. Epub 2017 Apr 17. Review.

PMID:
28415858
8.

Corrigendum: Towards clinical application of pronuclear transfer to prevent mitochondrial DNA disease.

Hyslop LA, Blakeley P, Craven L, Richardson J, Fogarty NM, Fragouli E, Lamb M, Wamaitha SE, Prathalingam N, Zhang Q, O'Keefe H, Takeda Y, Arizzi L, Alfarawati S, Tuppen HA, Irving L, Kalleas D, Choudhary M, Wells D, Murdoch AP, Turnbull DM, Niakan KK, Herbert M.

Nature. 2016 Oct 27;538(7626):542. doi: 10.1038/nature19105. Epub 2016 Jul 27. No abstract available.

PMID:
27462813
9.

Towards clinical application of pronuclear transfer to prevent mitochondrial DNA disease.

Hyslop LA, Blakeley P, Craven L, Richardson J, Fogarty NM, Fragouli E, Lamb M, Wamaitha SE, Prathalingam N, Zhang Q, O'Keefe H, Takeda Y, Arizzi L, Alfarawati S, Tuppen HA, Irving L, Kalleas D, Choudhary M, Wells D, Murdoch AP, Turnbull DM, Niakan KK, Herbert M.

Nature. 2016 Jun 16;534(7607):383-6. doi: 10.1038/nature18303. Epub 2016 Jun 8. Erratum in: Nature. 2016 Oct 27;538(7626):542.

10.

Research into Policy: A Brief History of Mitochondrial Donation.

Craven L, Herbert M, Murdoch A, Murphy J, Lawford Davies J, Turnbull DM.

Stem Cells. 2016 Feb;34(2):265-7. doi: 10.1002/stem.2221. Epub 2015 Oct 27. No abstract available.

11.

The challenges of mitochondrial replacement.

Chinnery PF, Craven L, Mitalipov S, Stewart JB, Herbert M, Turnbull DM.

PLoS Genet. 2014 Apr 24;10(4):e1004315. doi: 10.1371/journal.pgen.1004315. eCollection 2014 Apr. No abstract available. Erratum in: PLoS Genet. 2014 Jun;10(6):e1004472.

12.

Therapeutic potential of somatic cell nuclear transfer for degenerative disease caused by mitochondrial DNA mutations.

Greggains GD, Lister LM, Tuppen HA, Zhang Q, Needham LH, Prathalingam N, Hyslop LA, Craven L, Polanski Z, Murdoch AP, Turnbull DM, Herbert M.

Sci Rep. 2014 Jan 24;4:3844. doi: 10.1038/srep03844.

13.

Mitochondrial DNA disease: new options for prevention.

Craven L, Elson JL, Irving L, Tuppen HA, Lister LM, Greggains GD, Byerley S, Murdoch AP, Herbert M, Turnbull D.

Hum Mol Genet. 2011 Oct 15;20(R2):R168-74. doi: 10.1093/hmg/ddr373. Epub 2011 Aug 18. Review.

14.

Evolution of exceptional species richness among lineages of fleshy-fruited Myrtaceae.

Biffin E, Lucas EJ, Craven LA, Ribeiro da Costa I, Harrington MG, Crisp MD.

Ann Bot. 2010 Jul;106(1):79-93. doi: 10.1093/aob/mcq088. Epub 2010 May 11.

15.

Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease.

Craven L, Tuppen HA, Greggains GD, Harbottle SJ, Murphy JL, Cree LM, Murdoch AP, Chinnery PF, Taylor RW, Lightowlers RN, Herbert M, Turnbull DM.

Nature. 2010 May 6;465(7294):82-5. doi: 10.1038/nature08958. Epub 2010 Apr 14.

16.

Two children with subtelomeric 11q deletions: a description and interpretation of their clinical presentations and molecular genetic findings.

Cox H, Lucassen A, Rio M, Browne C, Renforth G, Craven L, Salmon T, Wilson DI.

Clin Dysmorphol. 2009 Apr;18(2):98-102. doi: 10.1097/MCD.0b013e3283202a1f.

PMID:
19077675
17.

Experimental strategies towards treating mitochondrial DNA disorders.

Gardner JL, Craven L, Turnbull DM, Taylor RW.

Biosci Rep. 2007 Jun;27(1-3):139-50. Review.

PMID:
17492502
18.

The reinforcement enhancing effects of nicotine depend on the incentive value of non-drug reinforcers and increase with repeated drug injections.

Palmatier MI, Matteson GL, Black JJ, Liu X, Caggiula AR, Craven L, Donny EC, Sved AF.

Drug Alcohol Depend. 2007 Jun 15;89(1):52-9. Epub 2007 Jan 19.

19.

Structural partitioning, paired-sites models and evolution of the ITS transcript in Syzygium and Myrtaceae.

Biffin E, Harrington MG, Crisp MD, Craven LA, Gadek PA.

Mol Phylogenet Evol. 2007 Apr;43(1):124-39. Epub 2006 Aug 22.

PMID:
17070713
20.

Operant responding for conditioned and unconditioned reinforcers in rats is differentially enhanced by the primary reinforcing and reinforcement-enhancing effects of nicotine.

Chaudhri N, Caggiula AR, Donny EC, Booth S, Gharib M, Craven L, Palmatier MI, Liu X, Sved AF.

Psychopharmacology (Berl). 2006 Nov;189(1):27-36. Epub 2006 Sep 22.

PMID:
17019569
21.

Self-administered and noncontingent nicotine enhance reinforced operant responding in rats: impact of nicotine dose and reinforcement schedule.

Chaudhri N, Caggiula AR, Donny EC, Booth S, Gharib M, Craven L, Palmatier MI, Liu X, Sved AF.

Psychopharmacology (Berl). 2007 Feb;190(3):353-62. Epub 2006 Jul 18.

22.

Transmission of mitochondrial DNA disorders: possibilities for the future.

Brown DT, Herbert M, Lamb VK, Chinnery PF, Taylor RW, Lightowlers RN, Craven L, Cree L, Gardner JL, Turnbull DM.

Lancet. 2006 Jul 1;368(9529):87-9. No abstract available.

PMID:
16815383
23.

Dissociating the primary reinforcing and reinforcement-enhancing effects of nicotine using a rat self-administration paradigm with concurrently available drug and environmental reinforcers.

Palmatier MI, Evans-Martin FF, Hoffman A, Caggiula AR, Chaudhri N, Donny EC, Liu X, Booth S, Gharib M, Craven L, Sved AF.

Psychopharmacology (Berl). 2006 Mar;184(3-4):391-400. Epub 2005 Oct 25.

PMID:
16249908
24.

Sex differences in the contribution of nicotine and nonpharmacological stimuli to nicotine self-administration in rats.

Chaudhri N, Caggiula AR, Donny EC, Booth S, Gharib MA, Craven LA, Allen SS, Sved AF, Perkins KA.

Psychopharmacology (Berl). 2005 Jul;180(2):258-66. Epub 2005 Jan 29.

PMID:
15682294
25.

Paralogy and orthology in the MALVACEAE rpb2 gene family: investigation of gene duplication in hibiscus.

Pfeil BE, Brubaker CL, Craven LA, Crisp MD.

Mol Biol Evol. 2004 Jul;21(7):1428-37. Epub 2004 Apr 14.

PMID:
15084680
26.

Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis.

Kennedy L, Evans E, Chen CM, Craven L, Detloff PJ, Ennis M, Shelbourne PF.

Hum Mol Genet. 2003 Dec 15;12(24):3359-67. Epub 2003 Oct 21.

PMID:
14570710
27.

Narrowing the critical region within 11q24-qter for hypoplastic left heart and identification of a candidate gene, JAM3, expressed during cardiogenesis.

Phillips HM, Renforth GL, Spalluto C, Hearn T, Curtis AR, Craven L, Havarani B, Clement-Jones M, English C, Stumper O, Salmon T, Hutchinson S, Jackson MS, Wilson DI.

Genomics. 2002 Apr;79(4):475-8.

PMID:
11944976
28.

Prevention of coronary and cerebral thrombosis.

CRAVEN LL.

Miss Valley Med J. 1956 Sep;78(5):213-5. No abstract available.

PMID:
13358612
29.

Appendicitis or ureteritis (pyelitis)? a problem in differential diagnosis.

CRAVEN LL.

Miss Valley Med J. 1953 Sep;75(5):134-7. No abstract available.

PMID:
13086890
30.

Experiences with aspirin (Acetylsalicylic acid) in the nonspecific prophylaxis of coronary thrombosis.

CRAVEN LL.

Miss Valley Med J. 1953 Jan;75(1):38-44. No abstract available.

PMID:
13013156
31.

Coronary thrombosis can be prevented.

CRAVEN LL.

J Insur Med. 1950 Sep-Nov;5(4):47-8. No abstract available.

PMID:
14803769
32.

Acetylsalicylic acid, possible preventive of coronary thrombosis.

CRAVEN LL.

Ann West Med Surg. 1950 Feb;4(2):95. No abstract available.

PMID:
15403207
33.

Supplemental Content

Loading ...
Support Center